STATINS USE IN INRACEREBRAL HEMORRHAGE PATIENTS (SATURN)

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Ich
  • Age: Between 50 - 110 Years
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Participants with Spontaneous lobar ICH confirmed by CT or MRI scan
    2. Participants was taking a statin drug at the onset of the qualifying/index ICH
    3. Those who can be randomized can be carried out within 7 days of the onset of the qualifying ICH
    4. Participants or legally authorized representative, after consultation with physicians, agrees to be randomized to statin continuation (restart) vs. discontinuation

You may not be eligible for this study if the following are true:

    1. Participants who has suspected secondary cause for the qualifying ICH, such as an underlying vascular abnormality or tumor, trauma, venous infarction, or hemorrhagic transformation of an ischemic infarct.
    2. History of recent myocardial infarction or unstable angina within the previous 3 months
    3. Diabetic patients with history of myocardial infarction or coronary revascularization
    4. History of familial hypercholesterolemia
    5. Participants receiving proprotein convertase subtilisin kexin 9 (PCSK9) inhibitors
    6. Known diagnosis of severe dementia
    7. Inability to obtain informed consent
    8. Participants with drug abuse or alcohol abuse
    9. Life expectancy of less than 24 months



If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.